During the opening lecture at the International Conference on Advanced Technologies & Treatments for Diabetes, Melanie Davies, CBE, MB, ChB, MD, FRCP, FRCGP, professor of diabetes medicine at the University of Leicester and an honorary consultant diabetologist at the University Hospitals of Leicester NHS Trust, reviewed how GLP-1 receptor agonists such as semaglutide (Ozempic/Wegovy, Novo Nordisk) have changed the way providers approach the treatment of type 2 diabetes and obesity and discussed some of the medications that combine GLP-1 with other molecules
For instance, Zhang et al
AMAOX myocardial ischemic injury the dosages should be decreased by 50%, and then titrated up or down given the particular patient response
14 Adjust TRT Delivery If high hematocrit persists, your doctor might change your TRT delivery method, especially if youve been using intramuscular injections
Nature Reviews Cancer , 3 (4), 276285
Current evidence suggests semaglutide works best as a long-term or indefinite medication for most people